| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/06/2009 | CN101422450A Cajanus cajan L. natural medicine with blood sugar reduction and weight reduction function |
| 05/06/2009 | CN101422449A Nonoxinol pellicles film and preparation method and use thereof in preparing contraceptive medicine |
| 05/06/2009 | CN101422448A Miconazole nitrate film and preparation method and pharmacy use thereof |
| 05/06/2009 | CN101422447A Instant film preparation containing phenylephrine hydrochloride |
| 05/06/2009 | CN101422446A Vitamin K micro-capsule preparation method |
| 05/06/2009 | CN101422445A Preparation method and use of pidotimod effervescent tablets |
| 05/06/2009 | CN101422444A Tinidazol colon target biology adhesive tablet and preparation method thereof |
| 05/06/2009 | CN101422443A Fenofibrate osmotic pump controlled release preparation and preparation method thereof |
| 05/06/2009 | CN101422442A Levetiracetam osmotic pump controlled release tablet and preparation method thereof |
| 05/06/2009 | CN101422441A Nimesulide sustained-release tablet and preparation method thereof |
| 05/06/2009 | CN101422440A Hydrochlorothiazide-metroprolol succinate sustained-release drop pills and preparation method thereof |
| 05/06/2009 | CN101422439A Etoposide freeze-dry powder preparation for injection and preparation method thereof |
| 05/06/2009 | CN101422438A Composite diisopropyiarmini dichloroacetas freeze-dry preparation without adjuvant and preparation technique thereof |
| 05/06/2009 | CN101422437A Etoposide dry suspension and preparation method thereof |
| 05/06/2009 | CN101422435A Tilmicosin liposome preparation and preparation method thereof |
| 05/06/2009 | CN101422434A Liranaftate cream preparation method |
| 05/06/2009 | CN101422432A Tilmicosin nano-emulsion antibacterial drug and preparation method thereof |
| 05/06/2009 | CN101422430A Ketoconazole m-thymol liquor for treating skin tinea |
| 05/06/2009 | CN101422429A Water-soluble vitamin for injection and preparation method thereof |
| 05/06/2009 | CN101422428A Injection containing sodium pidotimod |
| 05/06/2009 | CN101422427A Magnesium isoglycyrrhizinate cream and preparation method and use thereof |
| 05/06/2009 | CN101422426A Nitroimidazoles medicine nano montmorillonite sustained-release agent and preparation method thereof |
| 05/06/2009 | CN101422425A Etretinate type medicine solid dispersion |
| 05/06/2009 | CN101422424A Mycophenolic acid medicine implantation agent and preparation method and use thereof |
| 05/06/2009 | CN101422408A Therapeutic method capable of replacing sacral vertebrae and releasing nerve compression with composite preparation |
| 05/06/2009 | CN100486083C DC motor |
| 05/06/2009 | CN100484964C New use of tremella heteropolysaccharide or its extract |
| 05/06/2009 | CN100484963C Exo-polysaccharide of lactobacillus casei and crude product, prepartion method and application |
| 05/06/2009 | CN100484962C Method for preparing Codonopsis pilosula polysaccharide extractive as Codonopsis pilosula active ingredient |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/06/2009 | CN100484953C Pseudoginsenoside-Pdq and its semi-synthesis process and medicine use |
| 05/06/2009 | CN100484951C Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient |
| 05/06/2009 | CN100484945C Method for preparing cefozopran hydrochloride, cefozopran hydrochloride powder injection and preparation method thereof |
| 05/06/2009 | CN100484944C N4-substited pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its preparation process and medicine composition |
| 05/06/2009 | CN100484940C Water-soluble camptothecine derivative and its preparation process and application thereof |
| 05/06/2009 | CN100484939C Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/06/2009 | CN100484937C Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 05/06/2009 | CN100484936C Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone |
| 05/06/2009 | CN100484935C Benzimidazole-derivatives as factor Xa inhibitors |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484929C Rod sage root extract and making method of its preparation |
| 05/06/2009 | CN100484928C Thiadiazoline derivative |
| 05/06/2009 | CN100484915C Process for extracting leonuridine from fresh motherwort and leonuridine preparation |
| 05/06/2009 | CN100484574C Hydrochloric acid cefetamet pivoxil dispersible tablet and method for preparing the same |
| 05/06/2009 | CN100484565C Compound skins lintement of Chinese medicine |
| 05/06/2009 | CN100484563C Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 05/06/2009 | CN100484558C Ginseng freeze-drying powdery injection and its quality control method |
| 05/06/2009 | CN100484556C Medicament for treating tonsillitis, preparation process and using method thereof |
| 05/06/2009 | CN100484554C Liniment for treating arthralgia syndrome and preparing process thereof |
| 05/06/2009 | CN100484536C Capsule for treating enteritis and dysentery and its preparing process |
| 05/06/2009 | CN100484535C Medicine for treating toothache |
| 05/06/2009 | CN100484530C Azithromycin mix suspension grain and method for preparing the same |
| 05/06/2009 | CN100484529C Cardiac and cerebral vascular disease treating medicinal composition |
| 05/06/2009 | CN100484528C Pharmaceutical composition containing prostaglandin |
| 05/06/2009 | CN100484527C Sustained release formulation containing effective active component of galanthamin and its preparation process |
| 05/06/2009 | CN100484526C Compounding method of cefpirome sulfate raw material and uses thereof |
| 05/06/2009 | CN100484525C Pantoprazole sodium freeze-dried powder injection and preparing method thereof |
| 05/06/2009 | CN100484524C Thiazolidine carboxamide derivatives as modulators of the prostaglandin receptor |
| 05/06/2009 | CN100484523C Chinese medicinal preparation of sedum extract and preparation process thereof |
| 05/06/2009 | CN100484522C Chinese medicinal preparation for treating tumour and preparation process thereof |
| 05/06/2009 | CN100484521C A nano emulation antibacterial medicine of furacillin and preparation method thereof |
| 05/06/2009 | CN100484520C 5-aminoketone valerate externally-applied preparation and production thereof |
| 05/06/2009 | CN100484517C Smash-resisting panax notoginseng total saponin free-dried powdery injection and its preparation |
| 05/06/2009 | CN100484516C Cefamandole nafate powder injection, production method of powder injection and raw machine thereof |
| 05/06/2009 | CN100484515C Guacetisal dry-mixing suspending agents and method of preparing the same |
| 05/06/2009 | CN100484512C Method for preparing high oxygen large transfusion fluid |
| 05/06/2009 | CN100484400C Diphenylethylene compound |
| 05/05/2009 | USRE40707 Use of carbazole compounds for the treatment of congestive heart failure |
| 05/05/2009 | US7528274 For therapy of viral infections, particularly those caused by retroviruses |
| 05/05/2009 | US7528265 Process for the preparation of simvastatin |
| 05/05/2009 | US7528259 e.g. 2-methylamino-4,5,6,7-tetrabromo-1H-benzimidazole; caseine (serine/threonine family) kinase 2 inhibitor; anticrcinogenic, antitumor agen; leukemia |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528176 organic field effect transistor device comprising semiconductor component (comprises a composition of thiophene-carbonyl compounds and polymer); enhanced solubility in a solvent and thermal stablity; promote electron and hole mobilities; in thermal analysis, molecular spectroscopy, electrochemistry |
| 05/05/2009 | US7528175 Method of treating airway diseases with beta-adrenergic inverse agonists |
| 05/05/2009 | US7528174 Conjugates of Gramicidin S peptidyl fragments, tetramethylpentamethylene nitroxide and derivatives; hemorrhagic shock, myocardial ischemia, myocardial reperfusion, solid organ transplantation, hemorrhagic shock, septic shock, stroke, tissue damage due to ionizing radiation, lung injury, acute lung injury |
| 05/05/2009 | US7528173 Plasma carboxypeptidase B inhibitors |
| 05/05/2009 | US7528172 Compositions and methods for improving recovery after general anesthesia |
| 05/05/2009 | US7528171 Composition for external application |
| 05/05/2009 | US7528170 Sulfonamide derivatives for the treatment of diseases |
| 05/05/2009 | US7528169 drugs separated from fermentation cultures of filamentous fungi, having angiogenesis inhibitory activity in a low oxygen condition |
| 05/05/2009 | US7528168 Administering 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester (Etomoxir) for therapy of psoriasis |
| 05/05/2009 | US7528167 Inhibitors of papilloma virus |
| 05/05/2009 | US7528166 Lignan derivatives |
| 05/05/2009 | US7528165 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528161 NF-kappaB inhibitors and uses thereof |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528159 e.g. N-[5-(2-Chloro-phenyl)-pyridin-2-yl]-5-fluoro-2-methyl-benzenesulfonamide; 11beta-hydroxysteroid dehydrogenases (11beta-HSD's) inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, metabolic syndrome, obesity |
| 05/05/2009 | US7528158 Indazolone derivatives useful as 11b-HSD1 inhibitors |
| 05/05/2009 | US7528157 EP4 receptor antagonists |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528155 1H-Indazol-3-yl 4-methylpiperidine-1-carboxylate; synergistic mixture with antidiabetic agent, lipid modulators, and other active ingredients for the treatment of disorders of fatty acid metabolism, glucose utilization, and insulin resistance disease |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528153 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |